Alamar Biosciences, Inc. reposted this
📣 ICYMI! Tune in to hear Mendelspod's Theral Timpson and our CEO, Yuling Luo, discuss the current proteomics industry, the future of protein biomarker detection, and how our #NULISA and #ARGO HT technology is impacting research in the hot areas of Alzheimer’s and inflammatory disease. Full episode out now 👉 https://lnkd.in/gWq93q3e
#AAIC2024 is less than two weeks away! Don't miss our Product Theater on July 30, 12:25-1:05 pm, featuring presentations from Amanda Heslegrave of UCL and Thomas KariKari, PhD of University of Pittsburgh experience pTau and beyond, with the #NULISAseq CNS Disease Panel 120 for high sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids. Stop by booth 936 for a live demo of the #ARGO HT System or click the link to book a meeting with our team to discuss your research goals 👉 https://ow.ly/jjlw50SEFwj #ENDALZ #AlzheimersResearch #proteomics
We're excited to return to #AAIC2024 in Philadelphia, PA! Join us as we showcase our groundbreaking #NULISA and #ARGO HT protein biomarker detection technology for pTau and beyond in the fight against #Alzheimer’s disease. Stay tuned for more details and follow us for updates on our Product Theater, posters and more! https://ow.ly/pTn350SBWXC #ENDALZ #AlzheimersResearch
Have you listened yet? Exciting news in Proteomics! 🔬🎙️ Tune in to the debut of the Alamar podcast series with Mendelspod host Theral Timpson as he sits down with Alamar CEO, Yuling Luo, and discusses groundbreaking advancements in the #proteomics industry, the future of protein #biomarker detection, and how our #NULISA and #ARGO HT technology is impacting research in the hot areas of #Alzheimer’s and inflammatory disease. 🔗 Listen now! https://ow.ly/SGgf50SuR4q
🎙️ Exciting News! Join us for the latest episode of Mendelspod as we deep dive into the groundbreaking advancements in #Alzheimer's research with Dr. Henrik Zetterberg, one of the world's leading experts from the University of Gothenburg. 🧠 Until recently, Alzheimer’s research faced immense challenges, but today, the tide has turned. Discover how the field has surged forward with new hope, FDA-approved drugs, and promising biomarkers and innovative technologies (like #NULISA) that could transform early diagnosis and treatment. New episode out now 👉 https://ow.ly/FJ6150Sxr08
Happening today! Join Xiao-Jun Ma, CTO at Alamar, during the Satellite Symposium, for a fireside chat on Translating Innate and Adaptive Immune Therapies. Tune in at 16:35 to get an exclusive look at the cutting-edge capabilities of #NULISA and the #ARGO HT System. See you there 👋 https://ow.ly/XxvC50StlXQ #immunology #proteomics
✈ We're headed to Berlin! Join us on July 3 for a discussion on the latest advances in protein biomarker research where local scientists will present their recent discoveries utilizing our #NULISA and #ARGO HT technology for high sensitivity protein detection. 👉 Click the link to register! https://bit.ly/4eGbALl
We are here live at the 2nd Annual Symposium for Human Proteome and Health in Oxford, UK! Join Alamar's Alex Forrest-Hay at 09:45 during the Advances in Proteomics Technology session for an exclusive look at the next generation of #proteomics technology and learn about the cutting-edge capabilities of #NULISA. Learn more 👉 https://ow.ly/Wr6t50SqxbW
